Development of next-generation pharmacotherapy for opioid use disorders
Ended Cooperative Agreement Awarded Last action
- Award ID
- UG3DA048371
- Recipient
-
Astraea Therapeutics LLC UEI ZNNQAFC5FXH3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,916,188
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,458,094 | |
| Amendment | -$1,458,094 | |
| Amendment | $145,809 | |
| Amendment | $1,312,285 | |
| Original award | $1,458,094 |
Show all 11
Quick answers
Who received award UG3DA048371?
UG3DA048371 was awarded to Astraea Therapeutics LLC by National Institute on Drug Abuse (National Institutes of Health) on January 1, 2019.
How much is award UG3DA048371 worth?
$2,916,188 has been obligated on UG3DA048371.
Which agency awarded UG3DA048371?
National Institute on Drug Abuse (National Institutes of Health) awarded UG3DA048371, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award